deltatrials
Completed PHASE2 NCT00002472

Cisplatin and Etoposide Prior to Radiation Therapy in Treating Patients With CNS Tumors

Phase II Pre-Irradiation Chemotherapy for Central Nervous System Germ Cell Malignancies

Sponsor: Mayo Clinic

Conditions Brain and Central Nervous System Tumors Extragonadal Germ Cell Tumor Pediatric Germ Cell Tumor
Interventions cisplatin conventional surgery etoposide neoadjuvant therapy radiation therapy
Updated 6 times since 2017 Last updated: Mar 14, 2011 Started: Mar 31, 1991 Primary completion: Aug 31, 2005 Completion: Aug 31, 2005

This PHASE2 trial investigates Brain and Central Nervous System Tumors and Extragonadal Germ Cell Tumor and is currently completed. Mayo Clinic leads this study, which shows 6 recorded versions since 1991 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE2

  5. Feb 2017 — Jun 2018 [monthly]

    Completed PHASE2

▶ Show 1 earlier version

  1. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE2

    First recorded

Mar 1991

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Mayo Clinic
  • National Cancer Institute (NCI)
Data source: Mayo Clinic

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Jacksonville, United States
  • • Rochester, United States
  • • Scottsdale, United States